![David Hirsch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hirsch
No open positions remaining
Profile
Dr. David J.
Hirsch was previously employed as a Chief Executive Officer & Director by Alpha-9 Oncology, Inc., an Independent Director by Poseida Therapeutics, Inc., an Independent Director by Molecular Templates, Inc., an Independent Director by Tricida, Inc., an Independent Director by Rapid Micro Biosystems, Inc., a Venture Partner by Longitude Capital Management Co LLC, a Vice President by Pequot Capital Management, Inc., a Vice President by Pequot Ventures, and an Engagement Manager by McKinsey & Co., Inc. He also served on the board at Amunix Pharmaceuticals, Inc., Inflazome Ltd., Velicept Therapeutics, Inc., Zavante Therapeutics, Inc., Collegium Pharmaceutical, Inc., Civitas Therapeutics, Inc., Predictive Oncology, Inc. and Helomics Corp.
He received his undergraduate degree from The Johns Hopkins University, a doctorate degree from Harvard Medical School and a doctorate degree from Massachusetts Institute of Technology.
Former positions of David Hirsch
| Companies | Position | End |
|---|---|---|
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Chief Executive Officer | 2025-11-09 |
| RAPID MICRO BIOSYSTEMS, INC. | Director/Board Member | 2024-10-31 |
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early, asset spin-out and recapitalization transactions. | Founder | 2024-05-31 |
| TRICIDA, INC. | Director/Board Member | 2023-05-31 |
| MOLECULAR TEMPLATES, INC. | Director/Board Member | 2023-04-30 |
Education of David Hirsch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Pequot Capital Management, Inc.
 Pequot Capital Management, Inc. Investment ManagersFinance Pequot Capital Management's investment philosophy is based on deep fundamental research and unbiased thematic analysis to identify and capitalize on market inefficiencies across an industry sector or a company's lifecycle. The firm invests in public equities, private equity, venture capital, distressed securities and a variety of fixed-income securities. Pequot Capital Management tends to invest in the stocks of US small-cap companies in the consumer services, health technology and commercial services sectors. They maintain a very high turnover rate. | Finance |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Rapid Micro Biosystems, Inc.
 Rapid Micro Biosystems, Inc. Industrial MachineryProducer Manufacturing Develops automation solutions for pharmaceutical and healthcare manufacturing products | Producer Manufacturing |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
FirstMark Capital LLC
 FirstMark Capital LLC Investment ManagersFinance FirstMark Capital invests in startup companies located in the United States, Canada and Europe primarily in New York and broader East Coast ecosystem. The firm focuses in consumer, enterprise and frontier technology sectors. It provides financing for early stage capital requirements. It acts as a lead investor. It also takes a seat on the board of directors. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Helomics Corp.
 Helomics Corp. Miscellaneous Commercial ServicesCommercial Services Provides cancer care development and treatment consulting services | Commercial Services |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early, asset spin-out and recapitalization transactions. | Finance |
Predictive Oncology, Inc.
 Predictive Oncology, Inc. Medical SpecialtiesHealth Technology Operates as a development stage company manufacturing an environmentally conscientious system for the collection and disposal of infectious fluids | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Velicept Therapeutics, Inc.
 Velicept Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures biopharmaceutical products | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Inflazome Ltd.
 Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicines for inflammatory diseases | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
- Stock Market
- Insiders
- David Hirsch
